ProKidney Corp. targets diabetic CKD with Rilparencel and expects Q2 2027 eGFR slope data for accelerated approval. Find out ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

Spanish scientist Dr Mariano Barbacid and his team have developed a targeted therapy that eliminated pancreatic tumours in mice, marking a significant breakthrough.

Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

Spanish researchers report a major pancreatic cancer breakthrough in mice, with a triple-drug therapy eliminating tumours by targeting the KRAS pathway, raising hopes for future human trials.

Led by renowned cancer biologist Mariano Barbacid, the researchers have managed to make pancreatic tumours completely and ...

A Spanish study wipes out pancreatic cancer in mice, causing viral claims of a cure. Breakthrough science or false hope?

Spain: In what could offer new hope for patients with pancreatic cancer, scientists at the Spanish National Cancer Research Centre (CNIO) have reported a major medical breakthrough. The ...

A string of clinical and regulatory milestones in the December quarter highlighted growing momentum for ASX health stocks ...

As images of Barbacid circulated alongside news of the study, parts of social media fixated not on the science but on his ...